{"id":"F2007B01066","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 6 of 1991)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1991","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62556,"registerId":"commonwealth-F2007B01066-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 6 of 1991)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 6 of 1991\n\nI, FIONA MARGARET HOWARTH, Principal Advisor, Health Care Access Division, Department of Health, Housing and Community Services and Delegate of the Minister of State for Health, Housing and Community Services, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1. This Declaration shall come into operation on 1 August 1991.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nDebrisoquine Sulphate\n\nDifenoxin Hydrochloride with Atropine Sulphate\n\nFlucytosine\n\nGlucose, Anhydrous with Sodium Chloride, Potassium Chloride, Citric Acid and Sodium Citrate\n\nProcarbazine Hydrochloride\n\nDated this eighteenth day of July 1991.\n\nFIONA HOWARTH\n\nPrincipal Advisor\n\nHealth Care Access Division\n\nDepartment of Health, Housing and Community Services\n\nDelegate of the Minister of State for Health, Housing and Community Services","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1614},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This declaration performs exactly the function intended by section 85(2AA) of the National Health Act 1953: removing specific pharmaceutical benefits from the PBS following advice from the Pharmaceutical Benefits Advisory Committee. There is no expansion beyond the original statutory purpose."},"complexity_factors":["Single operative provision with no conditional logic or exceptions","Schedule contains only 5 listed items","No cross-references beyond the enabling section (s 85(2AA))","Straightforward administrative delisting mechanism"],"plain_english_summary":"This declaration, effective 1 August 1991, removes five named medicines from Australia’s Pharmaceutical Benefits Scheme, meaning they will no longer be government‑subsidised and patients must pay the full commercial price. It’s an administrative decision by a senior Health Department delegate acting for the Health Minister, taken after advice from the independent Pharmaceutical Benefits Advisory Committee."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1991","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1991/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1991/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1991/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1991/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1991/documents"}}